Amlodipine

CHEBI:CHEBI_2668

Definition

A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Chemical Information

Molecular Formula
C20H25ClN2O5
Molecular Mass
408.87600
Charge
0
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC
InChI
InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
InChIKey
HTIQEAQVCYTUBX-UHFFFAOYSA-N

Alternative Names

  • 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
  • 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
  • amlodipine
  • Amlodipine Free Base
  • amlodipino
  • amlodipinum

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
17767
oboInOwl#hasDbXref
Wikipedia:Amlodipine
core#notation
CHEBI:2668

Additional References

Wikipedia:Amlodipine

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
17767
generic_name
Amlodipine Besylate (Process 1)
brand_name
Katerzia
oboInOwl#hasDbXref
Wikipedia:Amlodipine
oboInOwl#id
CHEBI:2668
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_38215
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
BFO_0000053
http://purl.obolibrary.org/obo/DRON_00020325
package_ndc
60687-496-01
product_ndc
63187-326
labeler_name
Daiichi Sankyo Inc.
marketing_start_date
19920731
application_number
ANDA207435
brand_name_base
Katerzia
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
SUSPENSION
has_treatment
http://purl.obolibrary.org/obo/DOID_0070233
spl_id
0e8788cc-8c04-6f26-e063-6294a90a9a81
package_description
90 TABLET in 1 BOTTLE (71093-147-03)
package_marketing_start_date
19-MAR-03
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_113394
owl#annotatedSource
t155659
owl#someValuesFrom
t3866940
listing_expiration_date
20241231
core#notation
CHEBI:2668
pharm_class_epc
Dihydropyridine Calcium Channel Blocker [EPC]
pharm_class
Dihydropyridines [CS]
pharm_class_pe
Increased Diuresis [PE]
pharm_class_cs
Dihydropyridines [CS]
pharm_class_moa
Calcium Channel Antagonists [MoA]
brand_name_suffix
2.5 mg
upc
0300696565303
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
route
ORAL
manufacturer_name
Daiichi Sankyo Inc.
active_ingredient_name
AMLODIPINE BENZOATE
active_ingredient_strength
35 kg/35kg
nui
N0000175566
spl_set_id
655a8751-5c51-91f6-e053-2991aa0ad4bf
rxcui
2184126
unii
XD75TQ8A2P